.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cipla
Citi
Medtronic
UBS
Fish and Richardson
Novartis
Federal Trade Commission
Fuji
Baxter

Generated: December 17, 2017

DrugPatentWatch Database Preview

Patents Expiring in May 2017

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Pf Prism CvZMAXazithromycinFOR SUSPENSION, EXTENDED RELEASE;ORAL050797-001Jun 10, 2005RXYesYes► Subscribe► SubscribeY
LillyPROZAC WEEKLYfluoxetine hydrochlorideCAPSULE, DELAYED REL PELLETS;ORAL021235-001Feb 26, 2001ABRXYesYes► Subscribe► SubscribeYMETHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION WITHOUT AN INCREASE IN NAUSEA
LillyPROZAC WEEKLYfluoxetine hydrochlorideCAPSULE, DELAYED REL PELLETS;ORAL021235-001Feb 26, 2001ABRXYesYes► Subscribe► SubscribeYMETHOD OF TREATING PEOPLE SUFFERING FROM DEPRESSION
AbbvieNIASPANniacinTABLET, EXTENDED RELEASE;ORAL020381-003Jul 28, 1997ABRXYesYes► Subscribe► SubscribeTREATMENT OF PRIMARY AND MIXED DYSLIPIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT
AbbvieNIASPANniacinTABLET, EXTENDED RELEASE;ORAL020381-003Jul 28, 1997ABRXYesYes► Subscribe► SubscribeREDUCTION IN TG BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT
AbbvieNIASPANniacinTABLET, EXTENDED RELEASE;ORAL020381-003Jul 28, 1997ABRXYesYes► Subscribe► SubscribeMETHOD OF TREATING HYPERLIPIDEMIA WITH NICOTINIC ACID BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT
AbbvieNIASPANniacinTABLET, EXTENDED RELEASE;ORAL020381-002Jul 28, 1997ABRXYesNo► Subscribe► SubscribeREDUCTION IN TG BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT
AbbvieNIASPANniacinTABLET, EXTENDED RELEASE;ORAL020381-002Jul 28, 1997ABRXYesNo► Subscribe► SubscribeREDUCTION IN ELEVATED TC AND LDL-C BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT
AbbvieNIASPANniacinTABLET, EXTENDED RELEASE;ORAL020381-002Jul 28, 1997ABRXYesNo► Subscribe► SubscribeREDUCTION IN RISK OF RECURRENT NONFATAL MYOCARDIAL INFARCTION BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT
AbbvieNIASPANniacinTABLET, EXTENDED RELEASE;ORAL020381-002Jul 28, 1997ABRXYesNo► Subscribe► SubscribeTREATMENT OF PRIMARY AND MIXED DYSLIPIDEMIA BY DOSING ONCE PER DAY IN THE EVENING OR AT NIGHT
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Moodys
Colorcon
AstraZeneca
Accenture
Julphar
Citi
US Army
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot